Altered retinoid concentrations, also based on potential novel lycopene-metabolites in the skin, might lead to altered nuclear hormone receptor pathway activation resulting in skin abnormalities and a further AD-specific phenotype. This evidence concerns the gene NR0B1 and Alzheimer disease.